IN THE NEWS
AERIE PHARMACEUTICALS COMMITS TO FIVE-YEAR GRANT TO FUND AWARD
The Chandler Grant Glaucoma Society (CGGS) is pleased to announce an exclusive five-year partnership with Aerie Pharmaceuticals, Inc., to fund the distinguished David L. Epstein Clinician-Scientist Research Award.
The CGGS created this award to honor Dr. Epstein, who is widely \considered to be one of the most influential leaders in the world of glaucoma and glaucoma research over the past 40 years.
The award is a small way to honor his commitment to the scientific understanding and cure of glaucoma through the support of promising clinician-scientists in research environments. As Joel Schuman, MD, past-president, CGGS, once wrote in a tribute to Dr. Epstein, his “greatest legacy is the army of clinician-scientists whom he inspired throughout his years.”
Learn About Glaucoma
Glaucoma is an eye disease that has been called the "sneak thief of sight" because permanent damage to the eye can occur before patient even notices symptoms. That is why early detection and management of this chronic disease is so important.
Chandler Grant Glaucoma Society | 850 Ridge Avenue | Pittsburgh, PA 15212
Phone: 412-321-5030 | Fax: 412-321-5323
Administrator: Nadine Popovich | firstname.lastname@example.org